Brinter
Brinter develops proprietary 3D bioprinting technology to manufacture medical-grade, bioabsorbable tissue implants. The company focuses on regenerative medicine applications, including orthopedic solutions for rotator cuff injuries and aesthetic implants. Its platform combines advanced materials with engineering to produce biosynthetic tissue solutions for the healthcare and research sectors.
Visit websiteSanta Monica, USA
Healthcare
Biotechnology
Medical Devices
Regenerative Medicine
Funding summary
- Total raised
- €1.2M
- Funding rounds
- 1
Investors in Brinter
Investors on record for Brinter. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Brinter?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors